Phosphatidylcholine-specific Phospholipase C Inhibition Down- Regulates CXCR4 Expression and Interferes with Proliferation, Invasion and Glycolysis in Glioma Cells

Overview

Journal PLoS One

Specialties General Medicine
Science

Date 2017 Apr 20

PMID 28423060

Citations 14

Authors

Laura Mercurio

Serena Cecchetti

Alessandro Ricci

Aurora Pacella

Giovanni Cigliana

Giuseppina Bozzuto

Franca Podo

Egidio Iorio

Giulia Carpinelli

Affiliations

Soon will be listed here.

Abstract

Background: The chemokine receptor CXCR4 plays a crucial role in tumors, including glioblastoma multiforme (GBM), the most aggressive glioma. Phosphatidylcholine-specific phospholipase C (PC-PLC), a catabolic enzyme of PC metabolism, is involved in several aspects of cancer biology and its inhibition down-modulates the expression of growth factor membrane receptors interfering with their signaling pathways. In the present work we investigated the possible interplay between CXCR4 and PC-PLC in GBM cells.

Methods: Confocal microscopy, immunoprecipitation, western blot analyses, and the evaluation of migration and invasion potential were performed on U87MG cells after PC-PLC inhibition with the xanthate D609. The intracellular metabolome was investigated by magnetic resonance spectroscopy; lactate levels and lactate dehydrogenase (LDH) activity were analyzed by colorimetric assay.

Results: Our studies demonstrated that CXCR4 and PC-PLC co-localize and are associated on U87MG cell membrane. D609 reduced CXCR4 expression, cell proliferation and invasion, interfering with AKT and EGFR activation and expression. Metabolic analyses showed a decrease in intracellular lactate concentration together with a decrement in LDH activity.

Conclusions: Our data suggest that inhibition of PC-PLC could represent a new molecular approach in glioma biology not only for its ability in modulating cell metabolism, glioma growth and motility, but also for its inhibitory effect on crucial molecules involved in cancer progression.

Citing Articles

Structure-activity relationship expansion and microsomal stability assessment of the 2-morpholinobenzoic acid scaffold as antiproliferative phosphatidylcholine-specific phospholipase C inhibitors.

Rees S, Rees T, Paulin E, Arnerich O, Leung E, Walker C RSC Med Chem. 2025; .

PMID: 39823042 PMC: 11734694. DOI: 10.1039/d4md00831f.

Cancer stem cells and their niche in cancer progression and therapy.

Liu Q, Guo Z, Li G, Zhang Y, Liu X, Li B Cancer Cell Int. 2023; 23(1):305.

PMID: 38041196 PMC: 10693166. DOI: 10.1186/s12935-023-03130-2.

Phosphatidylcholine-Specific Phospholipase C as a Promising Drug Target.

Eurtivong C, Leung E, Sharma N, Leung I, Reynisson J Molecules. 2023; 28(15).

PMID: 37570610 PMC: 10420013. DOI: 10.3390/molecules28155637.

Targeting the Sphingolipid Rheostat in Gliomas.

Zaibaq F, Dowdy T, Larion M Int J Mol Sci. 2022; 23(16).

PMID: 36012521 PMC: 9408832. DOI: 10.3390/ijms23169255.

Agent-based computational modeling of glioblastoma predicts that stromal density is central to oncolytic virus efficacy.

Jenner A, Smalley M, Goldman D, Goins W, Cobbs C, Puchalski R iScience. 2022; 25(6):104395.

PMID: 35637733 PMC: 9142563. DOI: 10.1016/j.isci.2022.104395.

References

Gagliardi F, Narayanan A, Reni M, Franzin A, Mazza E, Boari N . The role of CXCR4 in highly malignant human gliomas biology: current knowledge and future directions. Glia. 2014; 62(7):1015-23. DOI: 10.1002/glia.22669. View

Hu H, Juvekar A, Lyssiotis C, Lien E, Albeck J, Oh D . Phosphoinositide 3-Kinase Regulates Glycolysis through Mobilization of Aldolase from the Actin Cytoskeleton. Cell. 2016; 164(3):433-46. PMC: 4898774. DOI: 10.1016/j.cell.2015.12.042. View

Warburg O . On respiratory impairment in cancer cells. Science. 1956; 124(3215):269-70. View

Iorio E, Ricci A, Pisanu M, Bagnoli M, Podo F, Canevari S . Choline metabolic profiling by magnetic resonance spectroscopy. Methods Mol Biol. 2013; 1049:255-70. DOI: 10.1007/978-1-62703-547-7_19. View

Fu D, Ma Y, Wu W, Zhu X, Jia C, Zhao Q . Cell-cycle-dependent PC-PLC regulation by APC/C(Cdc20)-mediated ubiquitin-proteasome pathway. J Cell Biochem. 2009; 107(4):686-96. DOI: 10.1002/jcb.22163. View

Hong X, Jiang F, Kalkanis S, Zhang Z, Zhang X, deCarvalho A . SDF-1 and CXCR4 are up-regulated by VEGF and contribute to glioma cell invasion. Cancer Lett. 2005; 236(1):39-45. DOI: 10.1016/j.canlet.2005.05.011. View

Cairns R, Harris I, Mak T . Regulation of cancer cell metabolism. Nat Rev Cancer. 2011; 11(2):85-95. DOI: 10.1038/nrc2981. View

Ehtesham M, Winston J, Kabos P, Thompson R . CXCR4 expression mediates glioma cell invasiveness. Oncogene. 2006; 25(19):2801-6. DOI: 10.1038/sj.onc.1209302. View

Dang C . Links between metabolism and cancer. Genes Dev. 2012; 26(9):877-90. PMC: 3347786. DOI: 10.1101/gad.189365.112. View

10.

Ali M, Kumar S, Shankar A, Varma N, Iskander A, Janic B . Effects of tyrosine kinase inhibitors and CXCR4 antagonist on tumor growth and angiogenesis in rat glioma model: MRI and protein analysis study. Transl Oncol. 2014; 6(6):660-9. PMC: 3890700. DOI: 10.1593/tlo.13559. View

11.

Zhou Y, Larsen P, Hao C, Yong V . CXCR4 is a major chemokine receptor on glioma cells and mediates their survival. J Biol Chem. 2002; 277(51):49481-7. DOI: 10.1074/jbc.M206222200. View

12.

Podo F, Canevari S, Canese R, Pisanu M, Ricci A, Iorio E . MR evaluation of response to targeted treatment in cancer cells. NMR Biomed. 2011; 24(6):648-72. DOI: 10.1002/nbm.1658. View

13.

Spinello I, Quaranta M, Riccioni R, Riti V, Pasquini L, Boe A . MicroRNA-146a and AMD3100, two ways to control CXCR4 expression in acute myeloid leukemias. Blood Cancer J. 2012; 1(6):e26. PMC: 3255264. DOI: 10.1038/bcj.2011.24. View

14.

Agnihotri S, Zadeh G . Metabolic reprogramming in glioblastoma: the influence of cancer metabolism on epigenetics and unanswered questions. Neuro Oncol. 2015; 18(2):160-72. PMC: 4724176. DOI: 10.1093/neuonc/nov125. View

15.

Cichocki M, Szaefer H, Krajka-Kuzniak V, Baer-Dubowska W . The effect of resveratrol and its methylthio-derivatives on EGFR and Stat3 activation in human HaCaT and A431 cells. Mol Cell Biochem. 2014; 396(1-2):221-8. PMC: 4176574. DOI: 10.1007/s11010-014-2157-5. View

16.

Ramoni C, Spadaro F, Barletta B, Dupuis M, Podo F . Phosphatidylcholine-specific phospholipase C in mitogen-stimulated fibroblasts. Exp Cell Res. 2004; 299(2):370-82. DOI: 10.1016/j.yexcr.2004.05.037. View

17.

Cecchetti S, Spadaro F, Lugini L, Podo F, Ramoni C . Functional role of phosphatidylcholine-specific phospholipase C in regulating CD16 membrane expression in natural killer cells. Eur J Immunol. 2007; 37(10):2912-22. DOI: 10.1002/eji.200737266. View

18.

Wu W, Zhao S . Metabolic changes in cancer: beyond the Warburg effect. Acta Biochim Biophys Sin (Shanghai). 2012; 45(1):18-26. DOI: 10.1093/abbs/gms104. View

19.

Cabioglu N, Summy J, Miller C, Parikh N, Sahin A, Tuzlali S . CXCL-12/stromal cell-derived factor-1alpha transactivates HER2-neu in breast cancer cells by a novel pathway involving Src kinase activation. Cancer Res. 2005; 65(15):6493-7. DOI: 10.1158/0008-5472.CAN-04-1303. View

20.

Scala S . Molecular Pathways: Targeting the CXCR4-CXCL12 Axis--Untapped Potential in the Tumor Microenvironment. Clin Cancer Res. 2015; 21(19):4278-85. DOI: 10.1158/1078-0432.CCR-14-0914. View